aidsmap news story
A number of innovative approaches to treating children were presented at CROI 2026. Several were based on the fact that infants have good prospects for long-term viral suppression without antiretroviral therapy. Failing that, children and adolescents, who may have particular problems with adherence to daily pills, are prime candidates for long-acting injectable formulations.
Globally, 1.4 million children under 14 have HIV, with 130,000 newly infected every year. Of them, only 57% are on ART and 46% virally suppressed.
Read the full news story here.
View all aidsmap reports from CROI 2026
Source : aidsmap
Related HIV and Co-Infections News
-
[Press release] FDA grants priority review of New Drug Application for Gilead’s once-daily HIV treatment of bictegravir plus lenacapavir
-
The Lancet Global Health: Untangling the complex relationship between HIV-exposure and TB in children: A narrative review
-
[CROI 2026] HIV i-Base: Investigational HIV combinations – daily, weekly, 4- and 6-monthly…
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.